COMMUNIQUÉS West-GlobeNewswire

Novartis announces new data that show Entresto® (sacubitril/valsartan) can be initiated early & safely in hospitalized patients after an acute heart failure episode
25/08/2018
TRANSITION shows that Entresto can be safely initiated shortly after an acute heart failure episode, both in the hospital and in an out-patient setting and in a wide range of stabilized patients[1] 83% of chronic heart [...]
Real-World Data Supports Association Between Elevated Triglyceride Levels and Increased Peripheral Arterial Revascularization in High Risk Statin-Treated Patients
25/08/2018
Management to Host Conference Call at 8:00 a.m. ET August 27, 2018 to Discuss Data Presented at European Society of Cardiology Congress BEDMINSTER, N.J. and DUBLIN, Ireland, Aug. 25, 2018 (GLOBE NEWSWIRE) -- Amarin [...]
Biotricity Issues Statement Regarding Recent Promotional Activity
24/08/2018
REDWOOD CITY, Calif., Aug. 24, 2018 (GLOBE NEWSWIRE) -- Biotricity, Inc. (OTCQB:BTCY) (the “Company”) announced today that it has been made aware of and requested by the OTC Markets Group, Inc. to comment on recent [...]
MPX to Report Fiscal First Quarter 2019 Earnings on Wednesday, August 29, 2018
24/08/2018
TORONTO, Aug. 24, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF), today announced the Company will issue its fiscal first quarter 2019 results release on August [...]
American ‘Healthcare Voters’ Are Deceived about the Real Problems, States the Association of American Physicians and Surgeons (AAPS)
24/08/2018
TUCSON, Ariz., Aug. 24, 2018 (GLOBE NEWSWIRE) -- Recent polls show that “healthcare is the No. 1 issue for voters,” writes Robert Pearl in Forbes . Their concerns are quite valid, states the Association of American [...]
Oasmia Pharmaceutical publishes the Annual Report for 2017/2018
24/08/2018
Oasmia Pharmaceutical’s Annual Report for the fiscal year 2017/2018 is now available at the company’s website, www.oasmia.com . For further information, please contact: Anders Blom, CFO Tel : +46 (0)18 – 50 54 40 E-mail [...]
BioSyent to Present at Upcoming Investor Conference
24/08/2018
TORONTO, Aug. 24, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”) (TSX Venture: RX) is pleased to announce that it will be presenting at the Midwest IDEAS Investor Conference at The Gwen in Chicago, [...]
Latvijas Juras medicinas centrs JSC: interim report for the 6 months of 2018.
24/08/2018
Latvia, 2018-08-24 15:06 CEST (GLOBE NEWSWIRE) -- Latvijas Juras medicinas centrs JSC: interim report for the 6 months of 2018, approved by the Board at 22.08.2018. Member of the Board: Juris Imaks, phone: 29512492
Clinical Genomics is proud to support Strides for Life and Super Bowel I
24/08/2018
Overcoming the stigma associated with colorectal cancer screening; former NFL players lead the way by undertaking colonoscopy and InSure ONE FIT testing in Super Bowel I BRIDGEWATER, N.J., Aug. 24, 2018 (GLOBE NEWSWIRE [...]
Solon Eiendom ASA – Major shareholding and primary insider notification
24/08/2018
(Oslo, Norway, August 24, 2018) Alden AS has today sold 6.044.556 shares in Solon Eiendom ASA at a price of NOK 30.00 per share. Owner of Alden AS, Edvin Austbø, is married to Solon Eiendom ASA Board Member Heidi [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
24/08/2018
FIT Biotech Oy Company release August 24, 2018 at 03:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
Adverum Biotechnologies Receives Orphan Drug Designation for ADVM-053, a Novel Gene Therapy Candidate for the Treatment of Hereditary Angioedema
24/08/2018
- ADVM-053 is a novel gene therapy candidate designed as a potential single‑administration treatment for hereditary angioedema (“HAE”) - Plans to submit an Investigational New Drug (IND) application to the FDA for ADVM- [...]
Hemispherx to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
24/08/2018
ORLANDO, Fla., Aug. 24, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology, announced [...]
SHIRE ANNOUNCES CASH TENDER OFFERS FOR UP TO $2,250,000,000 OUTSTANDING PRINCIPAL AMOUNT OF NOTES
24/08/2018
SHIRE ANNOUNCES CASH TENDER OFFERS FOR UP TO $2,250,000,000 OUTSTANDING PRINCIPAL AMOUNT OF NOTES Dublin, Ireland – August 24, 2018 – Shire plc (LSE: SHP and NASDAQ: SHPG) (“Shire”), Baxalta Incorporated, a Delaware [...]
Daxor Corporation Announces a 23 Percent Rise in BVA-100 Kit Sales in the Area of Cardiology and Filing of Form N-CSR for June 30, 2018
24/08/2018
NEW YORK, Aug. 24, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations filed a Form N-CSR disclosing its schedule of [...]
Federal Appeals Court Finds in Favor of Align and Vacates Patent Board’s Decision on ClearCorrect’s Challenge to Align Patent
24/08/2018
SAN JOSE, Calif., Aug. 24, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) announced today that on August 22, 2018 the United States Court of Appeals for the Federal Circuit (“Federal Circuit”) vacated [...]
Notice of Annual General Meeting in Oasmia Pharmaceutical AB
24/08/2018
THE SHAREHOLDERS OF OASMIA PHARMACEUTICAL AB ARE HEREBY GIVEN NOTICE OF THE ANNUAL GENERAL MEETING ON TUESDAY 25 SEPTEMBER 2018, AT 14:00 CET, AT THE OFFICES OF THE COMPANY, VALLONGATAN 1, 752 28 UPPSALA. THE [...]
American Cannabis Company, Inc. Comments on New Chief Financial Officer, Engagement of New Independent Auditor and SEC Filing Status
24/08/2018
DENVER, CO, Aug. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business consulting solutions provider, and seller of ancillary [...]
Emerald Health Therapeutics Engages Acorn Management Partners for Investor Relations
24/08/2018
VICTORIA, British Columbia, Aug. 24, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) today announced that it has engaged Acorn Management Partners, an Atlanta-based [...]

Pages